| Dr Praveen K Bolarum, MD | |
|
196 Thomas Johnson Dr Ste 135, Frederick, MD 21702 | |
| (301) 694-6688 | |
| (301) 694-8524 |
| Full Name | Dr Praveen K Bolarum |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 196 Thomas Johnson Dr Ste 135, Frederick, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073575015 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | D0062223 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Frederick Health Hospital, Inc | Frederick, MD | Home health agency |
| Frederick Health Hospital | Frederick, MD | Hospital |
| Autumn Lake Healthcare At Ballenger Creek | Frederick, MD | Nursing home |
| Entity Name | Upper Chesapeake Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497801419 PECOS PAC ID: 3173556974 Enrollment ID: O20050913000525 |
News Archive
Wolters Kluwer Health is pleased to announce a publishing partnership with the Egyptian Ministry of Higher Education and State Ministry for Scientific Research (ENSTINET). The two organizations have agreed to collaborate on the development and publication of leading medical and scientific journals and to help create a "Center of Excellence" in the region, bringing together the expertise of both parties.
Extend Health, operator of the nation's largest private Medicare exchange and a Towers Watson company, announced today the availability of two free guides designed to help seniors who are turning 65 - and becoming eligible for Medicare for the first time - navigate the complexity of their health care options to make informed choices about Medicare coverage.
Patient Safety Technologies, Inc. today announced financial results for its first quarter of 2011 ended March 31, 2011.
Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases, provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development.
An EORTC study published in Lancet Oncology found that health-related quality of life assessment in small-cell lung cancer randomized clinical trials provides relevant added information in studies where the treatment arms do not differ in terms of efficacy.
› Verified 8 days ago
| Entity Name | Praveen Bolarum Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568685287 PECOS PAC ID: 9638276199 Enrollment ID: O20070517000144 |
News Archive
Wolters Kluwer Health is pleased to announce a publishing partnership with the Egyptian Ministry of Higher Education and State Ministry for Scientific Research (ENSTINET). The two organizations have agreed to collaborate on the development and publication of leading medical and scientific journals and to help create a "Center of Excellence" in the region, bringing together the expertise of both parties.
Extend Health, operator of the nation's largest private Medicare exchange and a Towers Watson company, announced today the availability of two free guides designed to help seniors who are turning 65 - and becoming eligible for Medicare for the first time - navigate the complexity of their health care options to make informed choices about Medicare coverage.
Patient Safety Technologies, Inc. today announced financial results for its first quarter of 2011 ended March 31, 2011.
Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases, provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development.
An EORTC study published in Lancet Oncology found that health-related quality of life assessment in small-cell lung cancer randomized clinical trials provides relevant added information in studies where the treatment arms do not differ in terms of efficacy.
› Verified 8 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
Wolters Kluwer Health is pleased to announce a publishing partnership with the Egyptian Ministry of Higher Education and State Ministry for Scientific Research (ENSTINET). The two organizations have agreed to collaborate on the development and publication of leading medical and scientific journals and to help create a "Center of Excellence" in the region, bringing together the expertise of both parties.
Extend Health, operator of the nation's largest private Medicare exchange and a Towers Watson company, announced today the availability of two free guides designed to help seniors who are turning 65 - and becoming eligible for Medicare for the first time - navigate the complexity of their health care options to make informed choices about Medicare coverage.
Patient Safety Technologies, Inc. today announced financial results for its first quarter of 2011 ended March 31, 2011.
Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases, provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development.
An EORTC study published in Lancet Oncology found that health-related quality of life assessment in small-cell lung cancer randomized clinical trials provides relevant added information in studies where the treatment arms do not differ in terms of efficacy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Praveen K Bolarum, MD 196 Thomas Johnson Dr Ste 135, Frederick, MD 21702-4518 Ph: (301) 694-6688 | Dr Praveen K Bolarum, MD 196 Thomas Johnson Dr Ste 135, Frederick, MD 21702 Ph: (301) 694-6688 |
News Archive
Wolters Kluwer Health is pleased to announce a publishing partnership with the Egyptian Ministry of Higher Education and State Ministry for Scientific Research (ENSTINET). The two organizations have agreed to collaborate on the development and publication of leading medical and scientific journals and to help create a "Center of Excellence" in the region, bringing together the expertise of both parties.
Extend Health, operator of the nation's largest private Medicare exchange and a Towers Watson company, announced today the availability of two free guides designed to help seniors who are turning 65 - and becoming eligible for Medicare for the first time - navigate the complexity of their health care options to make informed choices about Medicare coverage.
Patient Safety Technologies, Inc. today announced financial results for its first quarter of 2011 ended March 31, 2011.
Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases, provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development.
An EORTC study published in Lancet Oncology found that health-related quality of life assessment in small-cell lung cancer randomized clinical trials provides relevant added information in studies where the treatment arms do not differ in terms of efficacy.
› Verified 8 days ago
Sandra J. Parkinson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Oak St, Frederick, MD 21703 Phone: 301-698-8374 Fax: 301-698-0182 | |
Dr. Hanna Siwiec, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3430 Worthington Blvd, Suite 103, Frederick, MD 21704 Phone: 240-215-6900 Fax: 240-436-6300 | |
Dr. Patrick Dunleavy Farrell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9093 Ridgefield Dr Ste 104, Frederick, MD 21701 Phone: 301-682-4100 | |
Stephen Herng-shiu Lee, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 610 Solarex Ct, Frederick, MD 21703 Phone: 301-682-5500 Fax: 301-663-8557 | |
Irfan Hassen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Toll House Ave, Suite D2, Frederick, MD 21701 Phone: 301-698-2604 Fax: 301-698-5307 | |
Dr. Naaz A Hussain, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Thomas Johnson Drive, Frederick, MD 21702 Phone: 301-696-1000 Fax: 301-696-1026 |